The company reported results for Q4 2021, ended Dec. It owns and operates productive longwall mining operations. It produces and exports metallurgical and other coal products. CONSOL Energy Inc.: CONSOL Energy is a coal mining company.The company mines and markets low sulfur coal for use by electric utility providers. Peabody Energy Corp.: Peabody Energy is a coal mining company with mines across the U.S.White was most recently Chief Executive Officer ( CEO) of Healthcareteams. White had joined Cross Country as its first chief commercial officer, responsible for overseeing sales, business development, program management, client, clinical and non-clinical services. On April 7, the company announced that Daniel J. It provides travel nurse, allied health, clinical research trials, and additional staffing services. Cross Country Healthcare Inc.: Cross Country Healthcare is a healthcare staffing company.The company serves customers across the U.S. It develops and produces crude oil, natural gas, and natural gas liquids in Colorado. Civitas Resources Inc.: Civitas Resources is an oil and natural gas company.These projects involve a single vertical well with the potential to yield oil at varying depths. The company focuses on low-cost, high-return operations in the Appalachian Basin known as 'stacked-pay' projects.

Range Resources Corp.: Range Resources is an independent natural gas and NGL producer.It operates high-speed cable, fiber optic, and fixed wireless networks that provide broadband services to customers throughout the U.S. Shenandoah Telecommunications Co.: Shenandoah Telecommunications is a broadband services provider.PYRUKYND 'successfully addressed the underlying cause of chronic hemolytic anemia in adults with PK deficiency,' according to he first author of the publication. On April 14, results from a company study of its drug PYRUKYND in adults with pyruvate kinase (PK) deficiency were published in the New England Journal of Medicine. Agios Pharmaceuticals Inc.:В Agios is a clinical-stage biopharmaceutical company that focuses on developing therapies for genetically defined diseases such as sickle cell disease, pyruvate kinase deficiency (PK), and thalassemia.Strong demand for new homes in the quarter helped to drive the revenue performance. For that quarter, the company saw net income increase by 30.9% while total revenues decreased by 1.6% year-over-year (YOY). Hovnanian reported Q1 2022 results for the period ending Jan. Its products include both individual townhouses and condominiums as well as higher-occupancy dwellings across the U.S. Hovnanian Enterprises Inc.: Hovnanian Enterprises designs, builds, and sells homes.

Publically listed micro cap stocks